Asia Pacific Expansion and Innovation for Biopharmas: Commercial, Funding and Scouting Models

Asia Pacific is home to 60% of the world population, 35% of the global GDP and 5 out of the top 15 pharmaceutical markets. It is also increasingly a source of innovation, whether from academia in Japan or start up biotechs in China. Join us in this discussion on the cross-border opportunities with the Asia Pacific market for international biopharmas, and how